News Releases

December 7, 2022

Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth Outlook

November 14, 2022

Indivior to Acquire Opiant Pharmaceuticals

October 27, 2022

Indivior Announces Q3 2022 Financial Results

October 5, 2022

Indivior to Announce Q3 / 9 Months YTD 2022 Results and Host Webcast on October 27th

September 30, 2022

Indivior Shareholders Approve Resolutions to Proceed with Additional U.S. Listing

September 6, 2022

Indivior To Participate in Upcoming Investor Healthcare Events

September 5, 2022

Indivior PLC (the 'Company') Publication of Circular and Notice of General Meeting

September 1, 2022

Indivior Recognizes National Recovery Month, Commits to Helping Move People living with Opioid Use Disorder onto a Path to Hope and Recovery

August 25, 2022

Indivior Publishes Exploratory Study Showing That Access to Medication for Opioid Use Disorder Varies Across Organized Health Systems in the U.S.

July 28, 2022

Indivior Announces H1 and Q2 2022 Financial Results